The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Interim analysis of ibrutinib plus paclitaxel for patients with advanced urothelial carcinoma previously treated with platinum-based chemotherapy.
 
Daniel E. Castellano
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Sanofi; Sanofi
Research Funding - Janssen Oncology (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pfizer; Roche
 
Rafael Morales-Barrera
Consulting or Advisory Role - AstraZeneca; MSD; Sanofi
Speakers' Bureau - Asofarma; MSD Oncology
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Clovis Oncology; Johnson & Johnson; Lilly; MSD; Roche/Genentech; Sanofi
 
Ignacio Duran
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Ipsen; Janssen Oncology; MSD Oncology; Roche/Genentech
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Janssen Oncology; MSD Oncology; Novartis; Pharmacyclics; Roche/Genentech; Seagen
Research Funding - Astellas Pharma (Inst); AstraZeneca Spain (Inst); Janssen Oncology (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Roche/Genentech
 
Bhumsuk Keam
Consulting or Advisory Role - AstraZeneca; Genexine; MSD Oncology
Research Funding - AstraZeneca; MSD Oncology; Ono Pharmaceutical
 
Ik Joo Chung
No Relationships to Disclose
 
Hendrik-Tobias Arkenau
No Relationships to Disclose
 
Ulka N. Vaishampayan
Honoraria - Bayer; Bristol-Myers Squibb; Exelixis; Genentech; Janssen; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Exelixis; Genentech/Roche; Pfizer
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Exelixis; Genentech/Roche; Pfizer; Sanofi
Research Funding - Astellas Pharma; Bristol-Myers Squibb; Exelixis; Novartis; Pfizer
 
Mark Tuthill
Employment - Personalized Medicine Limited (I)
Leadership - Personalized Medicine Limited
Stock and Other Ownership Interests - Personalized Medicine Limited
Honoraria - Bristol-Myers Squibb; Bristol-Myers Squibb; Janssen; Janssen; Novartis; Pfizer; Roche; Vaccitech; Vaccitech
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Janssen; Janssen; Novartis; Novartis; Pfizer; Pfizer; Roche; Roche; Vaccitech; Vaccitech
Speakers' Bureau - Astellas Pharma; Astellas Pharma; Bristol-Myers Squibb; Bristol-Myers Squibb; Genomic Health; Genomic Health; Novartis; Novartis; Pfizer; Pfizer; Roche; Roche
Travel, Accommodations, Expenses - Astellas Pharma; Astellas Pharma; Bristol-Myers Squibb; Bristol-Myers Squibb; EUSA Pharma; EUSA Pharma; Ipsen; Ipsen; Janssen; Janssen
 
Pablo Gajate
No Relationships to Disclose
 
Sang Joon Shin
No Relationships to Disclose
 
S. Paul Dang
No Relationships to Disclose
 
Chia-Hsin Ju
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
Travel, Accommodations, Expenses - Abbvie
 
Jennifer Lin
Employment - Pharmacyclics
Stock and Other Ownership Interests - Abbvie
 
George W. Cole
Employment - Pharmacyclics; Pharmacyclics
Stock and Other Ownership Interests - Abbvie; Abbvie
 
Danelle Frances James
Employment - Pharmacyclics
Stock and Other Ownership Interests - Abbvie; Abbvie (I)
Patents, Royalties, Other Intellectual Property - Abbvie Patent Applications
Other Relationship - Abbvie (I)
 
Oscar Reig
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Pfizer; Sanofi
Travel, Accommodations, Expenses - Ipsen